Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
Research and Development- Aoi #16+ Seeking to Manufacture and Obtain Regulatory Approval for the Cytotracker BV, a Poin… is a federal Unrestricted award for Barda - Aspr / Daappo / Barda Dcma held by Rizlab Health Inc. Estimated value $2.5M ($2.5M obligated). Current period of performance ends Apr 10, 2027. Last award drew 1 bidder. Place of performance: PRINCETON NJ. Related solicitation EZ-BAA-22-100-SOL-00003.
Research and development- aoi #16+ seeking to manufacture and obtain regulatory approval for the cytotracker bv, a point-of-care instant white blood cell analysis platform for discriminating between acute viral and bacterial infections. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Apr 10, 2027 (175 days remaining). Agencies typically plan 12–18 months ahead — at 5.7 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75A50123C00028? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRizlab Health Inc — $75K obligated across 2 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50123C00028?
75A50123C00028 (Research and development- aoi #16+ seeking) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $2.5M, currently held by Rizlab Health Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50123C00028?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00028 to Rizlab Health Inc (potential $2.5M).
Who is the incumbent on 75A50123C00028?
Rizlab Health Inc is the incumbent with $75K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Apr 10, 2027.
When does Rizlab Health Inc’s 75A50123C00028 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 10, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50123C00028? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.